We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+9.41%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$1.27B
AUM Growth
+$102M
Cap. Flow
+$13.4M
Cap. Flow %
1.05%
Top 10 Hldgs %
34.43%
Holding
2,813
New
122
Increased
1,063
Reduced
999
Closed
97

Sector Composition

Rank Sector Weight
1 Technology 15.34%
2 Financials 8.08%
3 Healthcare 7.07%
4 Consumer Staples 6.48%
5 Consumer Discretionary 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALTR
2226
DELISTED
Altair Engineering Inc
ALTR
$6.98K ﹤0.01%
81
FFBC icon
2227
First Financial Bancorp
FFBC
$3.55B
$6.97K ﹤0.01%
311
SHC icon
2228
Sotera Health
SHC
$5.04B
$6.87K ﹤0.01%
572
-427
-43% -$6.36K
PRFT
2229
DELISTED
Perficient Inc
PRFT
$6.87K ﹤0.01%
122
-38
-24% -$2.49K
PTON icon
2230
Peloton Interactive
PTON
$2.83B
$6.84K ﹤0.01%
1,597
+856
+116% +$4.23K
SPIB icon
2231
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$6.8K ﹤0.01%
+208
New +$6.79K
BBT
2232
Beacon Financial Corp
BBT
$2.51B
$6.79K ﹤0.01%
296
MP icon
2233
MP Materials
MP
$7.36B
$6.78K ﹤0.01%
474
-939
-66% -$14.9K
RLJ icon
2234
RLJ Lodging Trust
RLJ
$1.88B
$6.77K ﹤0.01%
573
+81
+16% +$953
VHT icon
2235
Vanguard Health Care ETF
VHT
$18.6B
$6.76K ﹤0.01%
25
ZUMZ icon
2236
Zumiez
ZUMZ
$346M
$6.76K ﹤0.01%
445
-1,309
-75% -$22.3K
ICHR icon
2237
Ichor Holdings
ICHR
$2.37B
$6.76K ﹤0.01%
175
+114
+187% +$4.41K
CRSP icon
2238
CRISPR Therapeutics
CRSP
$4.68B
$6.75K ﹤0.01%
99
-36
-27% -$2.58K
SCHX icon
2239
Schwab US Large- Cap ETF
SCHX
$71.3B
$6.7K ﹤0.01%
324
TBPH icon
2240
Theravance Biopharma
TBPH
$875M
$6.7K ﹤0.01%
747
+461
+161% +$4.27K
SAM icon
2241
Boston Beer
SAM
$1.93B
$6.7K ﹤0.01%
22
-3
-12% -$1K
WMK icon
2242
Weis Markets
WMK
$1.9B
$6.7K ﹤0.01%
104
+62
+148% +$3.88K
OSUR icon
2243
OraSure Technologies
OSUR
$276M
$6.59K ﹤0.01%
1,072
-148
-12% -$1.07K
BASE
2244
DELISTED
Couchbase
BASE
$6.58K ﹤0.01%
250
+76
+44% +$1.98K
DYN icon
2245
Dyne Therapeutics
DYN
$4.28B
$6.56K ﹤0.01%
231
SSYS icon
2246
Stratasys
SSYS
$691M
$6.52K ﹤0.01%
561
CECO icon
2247
Ceco Environmental
CECO
$3.95B
$6.47K ﹤0.01%
281
SLAB icon
2248
Silicon Laboratories
SLAB
$7.16B
$6.47K ﹤0.01%
45
UTI icon
2249
Universal Technical Institute
UTI
$2.14B
$6.41K ﹤0.01%
402
BRSL
2250
Brightstar Lottery PLC
BRSL
$1.92B
$6.39K ﹤0.01%
283
+38
+16% +$952

Similar funds

Quadrant Capital Group's Q1 2024 Portfolio in Review

As of Q1 2024, Quadrant Capital Group held 2,813 positions worth $1.27B, up 8.8% from $1.16B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Quadrant Capital Group's Q1 2024 filing shows 122 new, 1,063 increased, 999 reduced and 97 closed positions. Its largest new stake was GRIID Infrastructure Inc. Common Stock: 1,465,728 shares worth $1.93M. The largest sale was iShares Global Infrastructure ETF, an estimated $3.78M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • Quadrant Capital Group's largest Q1 2024 buy was GRIID Infrastructure Inc. Common Stock: 1,465,728 shares worth $1.93M.
  • Quadrant Capital Group added most to JPMorgan Ultra-Short Income ETF in Q1 2024, an estimated $8.28M increase.
  • Quadrant Capital Group's biggest Q1 2024 reduction was iShares Global Infrastructure ETF, cutting an estimated $3.78M.
  • Quadrant Capital Group fully exited INmune Bio in Q1 2024, selling an estimated $676K.
  • Quadrant Capital Group's ten largest holdings make up 34% of its $1.27B portfolio in Q1 2024.
  • Quadrant Capital Group opened 122 new positions and closed 97 in Q1 2024.
  • Quadrant Capital Group's portfolio value rose 8.8% quarter-over-quarter to $1.27B.

Based on Quadrant Capital Group's 13F filing for Q1 2024, filed 15 May 2024.